Corticosteroid Dosing Guidelines for Pediatric Conditions

Standard Dosing Framework

The American Academy of Pediatrics recommends starting with 1-2 mg/kg/day of prednisone or prednisolone, with a maximum of 60 mg/day, for most acute conditions requiring high-dose therapy 1, 2
For significantly overweight children, the dose should be calculated based on ideal body weight rather than actual weight to avoid excessive steroid exposure 1, 2
Administering the dose as a single daily dose in the morning minimizes suppression of the adrenal axis 1

For asthma exacerbations, 1-2 mg/kg/day (maximum 60 mg/day) for 3-10 days is recommended in children aged 0-11 years, with no tapering needed for courses less than 7 days 1
For autoimmune hepatitis, an initial dose of 1-2 mg/kg/day (up to 60 mg/day) for two weeks, either alone or combined with azathioprine 1-2 mg/kg/day, is recommended, with tapering over 6-8 weeks to a maintenance dose of 0.1-0.2 mg/kg/day or 5 mg/day 3
For nephrotic syndrome, an initial episode is treated with 60 mg/m²/day or 2 mg/kg/day (maximum 60 mg/day) as a single daily dose for 4-6 weeks, followed by 40 mg/m²/day or 1.5 mg/kg/day on alternate days for 2-5 months with gradual tapering 1, 2

For courses longer than 10 days, tapering should be done gradually, reducing by 5 mg every week until reaching 10 mg/day, then by 2.5 mg/week until reaching the maintenance dose 3, 2

Regular assessment for steroid-related adverse effects is necessary, particularly with prolonged use 1, 2
Monitoring growth in children on long-term therapy is recommended 1
Baseline and annual bone mineral density testing of the lumbar spine and hip should be performed for patients on long-term corticosteroids 3, 2

Systemic corticosteroids should not be used for bronchiolitis in infants under 2 years of age, as systematic reviews show insufficient evidence of benefit 4
The combination of prednisone with azathioprine reduces corticosteroid-related side effects compared to prednisone monotherapy 3, 2

The American College of Rheumatology recommends initiating calcium and vitamin D supplementation immediately when starting steroid therapy, and performing baseline and annual bone mineral density testing of lumbar spine and hip for long-term therapy, especially for high-dose therapy (≥30 mg daily for ≥30 days or cumulative dose ≥5 g over 1 year), to protect bone health in adolescents on prednisone therapy 5
Growth suppression is a significant concern in adolescents on long-term prednisone therapy, and tracking linear growth is essential, according to the Arthritis Care & Research journal 5

The British Journal of Dermatology suggests that mycophenolate mofetil 2-3 g per day can be used as an alternative to prednisone, allowing for lower maintenance doses (0.1-0.2 mg/kg/day or 5 mg/day) and reducing corticosteroid-related side effects 6

For autoimmune conditions, such as autoimmune hepatitis, the American Association for the Study of Liver Diseases recommends an initial dose of 40-60 mg daily (1-1.5 mg/kg/day) for 2 weeks, followed by a taper over 6-8 weeks to a maintenance dose of 4-8 mg daily (0.1-0.2 mg/kg/day) 7
The American Academy of Otolaryngology-Head and Neck Surgery suggests that for courses longer than 10-14 days, a structured taper should be used, reducing the dose by 5 mg every week until reaching 10 mg daily, then by 2.5 mg every week until reaching the maintenance dose, and finally by 1 mg monthly to reach the minimum effective dose 8

The American Association for the Study of Liver Diseases recommends performing baseline and annual bone mineral density testing of the lumbar spine and hip for long-term therapy (≥30 days at ≥30 mg daily or cumulative dose ≥5 g over 1 year) 7
The American Academy of Otolaryngology-Head and Neck Surgery notes that hyperglycemia is a common side effect to monitor, particularly in patients on long-term therapy 8

Combination therapy with azathioprine (when appropriate for autoimmune conditions) reduces corticosteroid-related side effects from 44% to 10% compared to prednisone monotherapy, according to the American Association for the Study of Liver Diseases 7
The American Academy of Otolaryngology-Head and Neck Surgery states that the commonly prescribed methylprednisolone dose pack is inadequate for most conditions requiring therapeutic corticosteroid dosing, as it provides only 84 mg total over 6 days (equivalent to 105 mg prednisone), compared to 540 mg prednisone over 14 days using standard dosing 8

The National Comprehensive Cancer Network guidelines recommend avoiding dexamethasone during induction therapy in 10-year-old children due to a significantly increased risk of osteonecrosis compared to prednisone 9
The NCCN guidelines demonstrate that dexamethasone is associated with higher osteonecrosis risk in patients 10 years or older, making prednisone the preferred corticosteroid at this age 9
Prednisone 60 mg/m²/day for 28 days is the preferred corticosteroid regimen at age 10 due to its lower risk of osteonecrosis 9

The Annals of the Rheumatic Diseases guidelines anticipate HPA axis suppression in patients receiving more than 7.5 mg of prednisone daily for more than 3 weeks 10, 11
To prevent adrenal insufficiency, a structured tapering protocol should be implemented for courses longer than 2 weeks, with a reduction of 5 mg every week until reaching 10 mg/day, then 2.5 mg/week until reaching maintenance dose, and finally 1 mg monthly to reach minimum effective dose 10, 11